Altered quantitative sensory testing outcome in subjects with opioid therapy
- 1 May 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Pain
- Vol. 143 (1), 65-70
- https://doi.org/10.1016/j.pain.2009.01.022
Abstract
Preclinical studies have suggested that opioid exposure may induce a paradoxical decrease in the nociceptive threshold, commonly referred as opioid-induced hyperalgesia (OIH). While OIH may have implications in acute and chronic pain management, its clinical features remain unclear. Using an office-based quantitative sensory testing (QST) method, we compared pain threshold, pain tolerance, and the degree of temporal summation of the second pain in response to thermal stimulation among three groups of subjects: those with neither pain nor opioid therapy (group 1), with chronic pain but without opioid therapy (group 2), and with both chronic pain and opioid therapy (group 3). We also examined the possible correlation between QST responses to thermal stimulation and opioid dose, opioid treatment duration, opioid analgesic type, pain duration, or gender in group 3 subjects. As compared with both group 1 (n = 41) and group 2 (n = 41) subjects, group 3 subjects (n = 58) displayed a decreased heat pain threshold and exacerbated temporal summation of the second pain to thermal stimulation. In contrast, there were no differences in cold or warm sensation among three groups. Among clinical factors, daily opioid dose consistently correlated with the decreased heat pain threshold and exacerbated temporal summation of the second pain in group 3 subjects. These results indicate that decreased heat pain threshold and exacerbated temporal summation of the second pain may be characteristic QST changes in subjects with opioid therapy. The data suggest that QST may be a useful tool in the clinical assessment of OIH.Keywords
This publication has 41 references indexed in Scilit:
- Opioid Tolerance and Hyperalgesia in Chronic Pain Patients After One Month of Oral Morphine Therapy: A Preliminary Prospective StudyThe Journal of Pain, 2006
- Oral opioid administration and hyperalgesia in patients with cancer or chronic nonmalignant painBritish Journal of Clinical Pharmacology, 2005
- Characterization of morphine-induced hyperalgesia in male and female ratsPain, 2005
- Short-term infusion of the μ-opioid agonist remifentanil in humans causes hyperalgesia during withdrawalPain, 2003
- Mechanisms of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphinPain, 2001
- Acute Opioid ToleranceAnesthesiology, 2000
- Rapid Development of Tolerance to Analgesia During Remifentanil Infusion in HumansAnesthesia & Analgesia, 1998
- Rapid Development of Tolerance to Analgesia During Remifentanil Infusion in HumansAnesthesia & Analgesia, 1998
- Hyperalgesic Response in a Patient Receiving High Concentrations of Spinal MorphineAnesthesiology, 1986
- A withdrawal hyperalgesia test for physical dependence: Evaluation of μ and mixed-partial opioid agonistsJournal of Pharmacological Methods, 1983